See Inflammation
Before It Surfaces

The Inflammation Proteins panel is a single blood test that measures 250+ inflammation-related proteins — cytokines, chemokines, and growth factors — in one draw. It is powered by Alamar Biosciences' NULISA proteomic technology and reviewed by longevity clinicians. The panel is designed as a proactive baseline to help you understand your underlying inflammatory profile and track how it changes over time. It is not a diagnostic test; rather, it gives you and your clinician a detailed, science-forward view that informs a personalized action plan.

NULISA is a next-generation proteomic technology developed by Alamar Biosciences. It measures proteins with attomolar sensitivity — detecting them at femtogram-per-milliliter levels — which means it can pick up low-abundance cytokines that many conventional assays miss. With a dynamic range of up to 12 logs without dilution and high reproducibility (under 10% intra- and inter-plate CV), NULISA delivers a remarkably precise and comprehensive picture of your inflammatory signaling from a very small sample.

Chronic, low-grade inflammation — often called "inflammaging" — has been associated with many of the conditions that shape how we age, including cardiovascular disease, metabolic disease, neurodegeneration, autoimmune conditions, and accelerated biological aging. Importantly, this kind of inflammation can be silent for years before any symptoms appear. Measuring your inflammatory proteins early gives you the opportunity to understand your profile and work with a clinician on a proactive plan. This panel measures markers associated with these pathways; it does not diagnose any specific disease.

The panel requires only a single, standard blood draw. NULISA technology can work from as little as 10µL of sample, so there is no need for large volumes or repeated visits. Your draw can be scheduled at one of our clinics or a partner location, and the sample is then processed using the NULISA proteomic platform. Most clients receive their clinician-reviewed report in approximately two weeks.

The panel is designed for health-focused adults who want a deeper, earlier understanding of their inflammatory health than standard bloodwork provides. It is especially relevant if you are optimizing for longevity, have a family history of cardiovascular, metabolic, or neurological conditions, or simply want a precise baseline to track over time. As with any advanced testing, results are most valuable when interpreted alongside your broader health picture by a qualified clinician — which is built into every panel.

The Inflammation Proteins panel is offered as a self-pay, proactive wellness service and is typically not covered by insurance, as it focuses on prevention and optimization rather than the diagnosis of a specific condition. However, the panel is FSA/HSA eligible. If you have questions about using your benefits, our client services team is happy to help you understand your options before you book.

Your panel is analyzed using NULISA proteomics and reviewed by a longevity clinician, who translates the data into a clear, personalized report and action plan. During your follow-up, every relevant finding is explained in plain language and you receive practical, prioritized next steps. If deeper evaluation or specialist input is warranted, you have access to our referral network of specialists nationwide. You can also re-test over time to measure how your inflammatory profile responds to changes in lifestyle, treatment, or other interventions.